FDA Inspection 1267742 — Matthew A. Cunningham, M.D.

Matthew A. Cunningham, M.D. — FEI 3036194617

The FDA completed an inspection of Matthew A. Cunningham, M.D. on April 18, 2025 in Orlando, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 18, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Orlando, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
722721 CFR 50.27(a)Consent form not approved/signed/dated
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance